Page last updated: 2024-11-07

2-acetylaminofluorene and Cancer of Esophagus

2-acetylaminofluorene has been researched along with Cancer of Esophagus in 3 studies

2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pozharisskiĭ, KM1
Tsuda, H2
Ogiso, T2
Hasegawa, R1
Imaida, K1
Masui, T1
Ito, N2
Shirai, T1
Hirose, M1

Reviews

1 review available for 2-acetylaminofluorene and Cancer of Esophagus

ArticleYear
[Successes of experimental oncology and problems of the study of the morphogenesis of tumors].
    Arkhiv patologii, 1975, Volume: 37, Issue:4

    Topics: 2-Acetylaminofluorene; 9,10-Dimethyl-1,2-benzanthracene; Aflatoxins; Animals; Azoxymethane; Benzopyr

1975

Other Studies

2 other studies available for 2-acetylaminofluorene and Cancer of Esophagus

ArticleYear
Inhibition of neoplastic development in rat liver, kidney, oesophagus and forestomach by 4,4'-diaminodiphenylmethane administration.
    Carcinogenesis, 1987, Volume: 8, Issue:5

    Topics: 2-Acetylaminofluorene; Aniline Compounds; Animals; Esophageal Neoplasms; Kidney Neoplasms; Liver Neo

1987
Organ specific modifying potential of ethinyl estradiol on carcinogenesis initiated with different carcinogens.
    Carcinogenesis, 1987, Volume: 8, Issue:1

    Topics: 2-Acetylaminofluorene; Animals; Cell Transformation, Neoplastic; Diethylnitrosamine; Drug Interactio

1987